MyShare
BGNE.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
| symbol | last | change | %chng | name | mcap | sector | wiki | |
|---|---|---|---|---|---|---|---|---|
BGNE | US | BeiGene Ltd |
Market global news for BGNE (US) BeiGene Ltd
Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
| BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report lelezard - 16:30 Fri 26 - BGNE - link story | |
| BeiGene's Tizveni receives EC approval to treat non-small cell lung cancer pmlive - 15:30 Fri 26 - BGNE - link story | |
| Brokerages Set BeiGene, Ltd. (NASDAQ:BGNE) PT at $251.70 theenterpriseleader - 10:30 Fri 26 - BGNE - link story | |
| BeiGene, Ltd. (NASDAQ:BGNE) Receives Consensus Rating of "Moderate Buy" from Analysts themarketsdaily - 10:30 Fri 26 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Trading 4.3% Higher After Analyst Upgrade theenterpriseleader - 16:30 Thu 25 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Trading 4.3% Higher After Analyst Upgrade themarketsdaily - 16:30 Thu 25 - BGNE - link story | |
| Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting - Iberonews iberonews - 21:30 Wed 24 - BGNE - link story | |
| Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting streetinsider - 21:15 Wed 24 - BGNE - link story | |
| Evaluating BeiGene: Insights From 6 Financial Analysts - BeiGene (NASDAQ:BGNE) benzinga - 19:30 Wed 24 - BGNE - link story | |
| TD Cowen Raises BeiGene (NASDAQ:BGNE) Price Target to $236.00 themarketsdaily - 18:15 Wed 24 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Given New $236.00 Price Target at TD Cowen theenterpriseleader - 18:15 Wed 24 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Shares Gap Up to $130.94 theenterpriseleader - 16:30 Tue 23 - BGNE - link story | |
| BeiGene Shares Rise 7% After European Approval of Tislelizumab Cancer Treatment marketscreener - 15:15 Tue 23 - BGNE - link story | |
| With 42% ownership of the shares, BeiGene, Ltd. (NASDAQ:BGNE) is heavily dominated by institutional owners yahoo - 14:45 Tue 23 - BGNE - link story | |
| BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer pipelinereview - 14:30 Tue 23 - BGNE - link story | |
| BeiGene, Ltd. Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer marketscreener - 12:45 Tue 23 - BGNE - link story | |
| BeiGene (BGNE) Receives EU Approval for Tislelizumab streetinsider - 10:30 Tue 23 - BGNE - link story | |
| BeiGene, Ltd.: BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer finanznachrichten de - 10:30 Tue 23 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Shares Down 2.4% themarketsdaily - 17:15 Fri 19 - BGNE - link story | |
| Baillie Gifford & Co. Sells 5,149 Shares of BeiGene, Ltd. (NASDAQ:BGNE) theenterpriseleader - 16:30 Tue 9 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Shares Gap Up to $149.75 wkrb13 - 15:45 Tue 9 - BGNE - link story | |
| Chinese billionaire Zhang Lei's Hillhouse logs hefty decline in hedge fund assets in 2023 dealstreetasia - 10:45 Mon 8 - BGNE - link story | |
| China's Hillhouse logs hefty decline in hedge fund assets in 2023 | The Mighty 790 KFGO kfgo - 08:45 Mon 8 - BGNE - link story | |
| China's Hillhouse Logs Hefty Decline in Hedge Fund Assets in 2023 usnews - 08:15 Mon 8 - BGNE - link story | |
| China Universal Asset Management Co. Ltd. Boosts Stake in BeiGene, Ltd. (NASDAQ:BGNE) wkrb13 - 15:30 Fri 5 - BGNE - link story | |
| China Universal Asset Management Co. Ltd. Increases Stake in BeiGene, Ltd. (NASDAQ:BGNE) tickerreport - 15:00 Fri 5 - BGNE - link story | |
| BeiGene, Ltd. (NASDAQ:BGNE) Receives $260.89 Consensus Target Price from Analysts theenterpriseleader - 10:30 Mon 1 - BGNE - link story | |
| BeiGene, Ltd. (NASDAQ:BGNE) Receives $260.89 Average PT from Brokerages themarketsdaily - 10:15 Mon 1 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Price Target Lowered to $161.00 at Sanford C. Bernstein theenterpriseleader - 06:30 Sun 31 - BGNE - link story | |
| JGP Global Gestao de Recursos Ltda. Has $1.78 Million Stock Position in BeiGene, Ltd. (NASDAQ:BGNE) wkrb13 - 17:30 Wed 27 - BGNE - link story | |
| BeiGene, Ltd. (NASDAQ:BGNE) Shares Sold by Matthews International Capital Management LLC themarketsdaily - 20:45 Mon 25 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Price Target Raised to $186.00 at JPMorgan Chase & Co. tickerreport - 15:00 Wed 20 - BGNE - link story | |
| BeiGene (NASDAQ:BGNE) Price Target Raised to $186.00 at JPMorgan Chase & Co. wkrb13 - 15:00 Wed 20 - BGNE - link story |